Maryland Senate passes bill restricting delta-8 and delta-10 sales to minors

Senate Bill 214, introduced in the Maryland Legislature on February 11, 2025, aims to regulate the sale of products containing delta-8 and delta-10 tetrahydrocannabinol (THC) by prohibiting their sale to individuals under the age of 21. This legislation responds to growing concerns about the accessibility of these cannabis-derived products to minors, particularly as their popularity has surged in recent years.

Key provisions of the bill include a requirement for sellers to verify the age of purchasers through valid identification, such as a driver’s license. Additionally, online sellers must implement age-verification mechanisms on their websites to ensure compliance. Violations of this law would result in misdemeanor charges, with escalating fines for repeat offenses: $300 for a first violation, $1,000 for a second within two years, and $3,000 for subsequent violations.

The bill has sparked discussions among lawmakers and stakeholders regarding its implications for public health and safety. Proponents argue that the measure is essential for protecting youth from potential harm associated with THC products, which can have psychoactive effects. Critics, however, express concerns about the enforcement of age verification and the potential for overregulation that could stifle legitimate businesses.

The economic implications of Senate Bill 214 are noteworthy, as the cannabis market continues to expand. Supporters believe that establishing clear regulations could foster a safer marketplace, while opponents worry that stringent rules might drive consumers to unregulated sources.

As the bill moves forward, it is set to take effect on July 1, 2025, pending approval from the Governor. The outcome of this legislation could significantly shape the landscape of cannabis product sales in Maryland, influencing both consumer behavior and industry practices.